Daniel Brennan analyst UBS

Currently out of the existing stock ratings of Daniel Brennan, 15 are a HOLD (55.56%), 9 are a BUY (33.33%), 3 are a SELL (11.11%).

Daniel Brennan

Work Performance Price Targets & Ratings Chart

Analyst Daniel Brennan works at UBS with a stock forecast success ratio of 66.42% fulfilled within 148.89 days on average. Previously, Daniel Brennan worked at COWEN.

Daniel Brennan’s has documented 223 price targets and ratings displayed on 18 stocks. The coverage is on Healthcare, Basic Materials sectors.

Most recent stock forecast was given on AVTR, Avantor at 14-Sep-2022.

Wall Street Analyst Daniel Brennan

Analyst best performing recommendations are on NVTA (INVITAE CORP).
The best stock recommendation documented was for ILMN (ILLUMINA) at 9/22/2020. The price target of $285 was fulfilled within 2 days with a profit of $16.49 (6.14%) receiving and performance score of 30.71.

Average potential price target upside

BRKR Bruker CRL Charles River Laboratories CTLT Catalent EXAS EXACT Sciences IQV IQVIA Holdings NEO NeoGenomics SLGC Somalogic TMO Thermo Fisher Scientific A Agilent Technologies AVTR Avantor ICLR ICON PLC ILMN Illumina MTD Mettler-Toledo International NVTA Invitae Corp TX Ternium SA ADR WAT Waters DHR Danaher NSTG NanoString Technologies

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

102

$11.77 (13.04%)

70

1 months 17 days ago

1/2 (50%)

$13.67 (15.48%)

76

Hold

81

$-9.23 (-10.23%)

78

2 months 4 days ago

6/6 (100%)

$1 (1.25%)

168

Buy

90

$-0.23 (-0.25%)

65

2 months 4 days ago

3/4 (75%)

$10 (12.50%)

104

Hold

62

$-28.23 (-31.29%)

79

5 months 15 days ago

4/4 (100%)

$3.26 (5.55%)

290

Sell

59

$-31.23 (-34.61%)

70

6 months ago

3/3 (100%)

$-1.09 (-1.81%)

236

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Daniel Brennan?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?